Citation: S. Ishido et al., Possible involvement of the NS3 protein of hepatitis C virus in hepatocarcinogenesis - Its interaction with the p53 tumor suppressor, METH MOL M, 45, 2000, pp. 37-55
Citation: Mr. Brunetto et al., The impact of hepatitis B virus (HBV) and hepatitis C virus (HCV) - From research to clinical practice, METH MOL M, 45, 2000, pp. 99-112
Citation: Y. Ohene-abuakwa et M. Pignatelli, Diagnostic markers in hepatocellular carcinoma using immunohistochemical techniques, METH MOL M, 45, 2000, pp. 131-138
Citation: Cg. Wu, Isolation of novel markers for hepatocellular carcinoma by a subtraction-enhanced display technique, METH MOL M, 45, 2000, pp. 157-165
Citation: T. Naka et al., Measurement of protein expression of p53, p21(WAF1), and Rb in patients with surgically treated hepatocellular carcinoma by using catalyzed signal-amplification system, METH MOL M, 45, 2000, pp. 167-173
Citation: S. Kaneko et T. Tamaoki, Gene therapy vectors harboring AFP regulatory sequences - Preparation of an adenoviral vector, METH MOL M, 45, 2000, pp. 177-187
Citation: P. Seth et J. Higginbotham, Advantages and disadvantages of multiple different methods of adenoviral vector construction, METH MOL M, 45, 2000, pp. 189-198
Citation: Ai. Chapoval et al., Immunoglobulin fusion proteins as a tool for evaluation of T-cell costimulatory molecules, METH MOL M, 45, 2000, pp. 247-255